Entering an era of intelligent combination therapy in cancerDecember 14, 2015Breast CancerLymphoma & Plasma Cell DisordersMelanomaImmunotherapy
Dinutuximab combination therapy becomes first approval for high-risk neuroblastomaOctober 19, 2015GastroenterologyImmunotherapy
Harnessing new data on immunotherapiesJuly 22, 2015Breast CancerGastroenterologyGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanomaPreventive Care
Oncogenic drivers and immunotherapy: staying one step ahead of lung cancerJuly 22, 2015Lung CancerImmunotherapy
ASCO 2015: from data and learning, to daily practiceJuly 22, 2015Breast CancerGastroenterologyHead & Neck/Thyroid CancersGenitourinary CancerLung CancerPreventive CareMelanoma
